Real-world Evaluation of the Impact of Baseline Metastases on Clinical Outcomes Among BRAF Positive Metastatic Melanoma Patients
Clinical trial NCT05984615 · COMPLETED
Trial details
- NCT number
- NCT05984615
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-08
- Primary completion
- 2022-08-24
- Enrollment
- 1961
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.